Treating and improving the quality of life for those with renal impairment shaped our mission, built our culture and remains our singular objective. Since 2001, our team has worked to become the only Phase I-IV drug and device clinical development services provider dedicated exclusively to renal research.
That says a lot — it says no other research partner has a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. As a Fresenius Medical Care North America (FMCNA) company, Frenova maintains a world-class network of kidney research resources. For example, the Frenova Renal Site Network encompasses more than 200 principal investigators and 250 dialysis research sites so you can fill renal trials faster and complete them more efficiently. And because we maintain the world’s largest database of de-identified renal patient data, we have the robust bioinformatics capabilities you need to quickly assess protocol feasibility and ensure viable patient recruitment and enrollment strategies.
When you need to conduct a complete renal clinical program, trust the partner that’s completely renal — Frenova Renal Research.
Start with the patient in mind
With more than 2,200 dialysis facilities and 200 principal investigators, Frenova has access to 183,000 active dialysis patients along with 390,000 active CKD patients in all demographic niches, in all stages of renal dysfunction and with a wide variety of comorbidities. That makes finding the right patients — even those with relatively rare conditions — fast and efficient.
Our 25 years of collected data on 980,000 ESRD patients include the results of almost 1 billion lab tests; our CKD database includes data from more than 390,000 active patients and is growing by more than 100,000 patients per year.
Combine this kind of patient data with clinical research professionals and principal investigators possessing deep knowledge and significant experience of those affected by kidney disease and its comorbid conditions and you have the opportunity to do research that goes beyond the standard — research that can lead the way to real breakthroughs in patient care.
All you have to do is start with the patient in mind.